Stock has gone from a lot of potential to real world results. Afrezza will only grow from here and only issue is how fast. We might still have a slow grind into the summer though the word is finally getting out with commercials, analyst coverage and new social media users spouting the benefits (sure didn't think it would take this long), yet adoption rates will continue to pick up with Endo's, GP's and diabetics.
Add in UTHR. RLS and Pediatrics along with new insurers (Humana & Kaiser) with VDEX continuing to add new centers and we could be cash flow positive this year which would reduce the need for anymore dilution.
Good things ahead just need to understand that we need to get institutional holdings over 50% and shorts down in the 15% instead of 30% range to get us really moving. Good area to accumulate more stock at these levels.
News 
Market Data 
Discover 
